US Stock MarketDetailed Quotes

Psyence Biomedical (PBM)

Watchlist
  • 0.7603
  • -0.1105-12.69%
Close Jan 22 15:59 ET
4.86MMarket Cap-0.36P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Psyence Biomedical (PBM) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Sep 30, 2025
(FY)Mar 31, 2025
(Q2)Sep 30, 2024
(FY)Mar 31, 2024
(Q2)Sep 30, 2023
(FY)Mar 31, 2023
(FY)Mar 31, 2022
(FY)Mar 31, 2021
Assets
Current assets
Cash, cash equivalents and short term investments
269.98%7.15M
736.78%6.14M
222.96%1.93M
-45.05%733.19K
--598.38K
-23.79%1.33M
-63.17%1.75M
--4.75M
-Cash and cash equivalents
269.98%7.15M
736.78%6.14M
222.96%1.93M
-45.05%733.19K
--598.38K
-23.79%1.33M
-63.17%1.75M
--4.75M
Receivables
39.26%174.19K
229.00%137.35K
569.37%125.08K
-72.05%41.75K
--18.69K
277.71%149.37K
-71.36%39.55K
--138.07K
-Other receivables
39.26%174.19K
229.00%137.35K
569.37%125.08K
-72.05%41.75K
--18.69K
277.71%149.37K
-71.36%39.55K
--138.07K
Prepaid assets
65.27%258.09K
-21.83%251.8K
911.68%156.16K
318.07%322.13K
--15.44K
1,329.54%77.05K
-1.24%5.39K
--5.46K
Restricted cash
59.37%47.19K
21.45%35.96K
-11.00%29.61K
0.19%29.61K
--33.27K
-18.41%29.56K
814.56%36.23K
--3.96K
Total current assets
240.09%7.63M
482.27%6.56M
236.96%2.24M
-29.15%1.13M
--665.78K
-13.20%1.59M
-62.63%1.83M
--4.9M
Non current assets
Net PPE
-14.18%8.69K
102.22%11.1K
--10.13K
--5.49K
----
--0
----
----
-Gross PPE
30.25%15.83K
172.46%15.6K
--12.16K
--5.73K
----
--0
----
----
-Accumulated depreciation
-252.00%-7.14K
-1,778.33%-4.51K
---2.03K
---240
----
--0
----
----
Investments and advances
--5.17M
--745K
----
--0
----
----
----
----
Total non current assets
51,062.26%5.18M
13,679.77%756.1K
--10.13K
--5.49K
--0
--0
--0
--0
Total assets
468.46%12.81M
546.23%7.32M
238.48%2.25M
-28.81%1.13M
--665.78K
-13.20%1.59M
-62.63%1.83M
--4.9M
Liabilities
Current liabilities
Payables
-70.72%235.87K
-53.42%261.94K
-11.48%805.61K
-65.46%562.35K
--910.08K
4,313.67%1.63M
174.29%36.89K
--13.45K
-accounts payable
-70.72%235.87K
-53.42%261.94K
-11.48%805.61K
-65.46%562.35K
--910.08K
4,313.67%1.63M
174.29%36.89K
--13.45K
Current accrued expenses
773.08%104.94K
-59.92%50.48K
--12.02K
-22.52%125.95K
----
71.34%162.56K
8.27%94.87K
--87.63K
Current provisions
642.55%303.9K
22.35%81.85K
--40.93K
--66.9K
----
----
----
----
Current debt and capital lease obligation
----
----
241.14%2.5M
--10.45M
--733.09K
----
----
----
-Current debt
----
----
241.14%2.5M
--10.45M
--733.09K
----
----
----
Other current liabilities
100.00%298.37K
-77.81%200.1K
--149.18K
--901.61K
----
----
----
----
Current liabilities
-73.12%943.07K
-95.09%594.37K
113.53%3.51M
575.98%12.1M
--1.64M
1,259.04%1.79M
30.36%131.76K
--101.08K
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
-73.12%943.07K
-95.09%594.37K
113.53%3.51M
575.98%12.1M
--1.64M
1,259.04%1.79M
30.36%131.76K
--101.08K
Shareholders'equity
Share capital
30.12%68.88M
33.88%61.75M
--52.94M
677.29%46.13M
----
--5.93M
----
----
-common stock
30.12%68.88M
33.88%61.75M
--52.94M
677.29%46.13M
----
--5.93M
----
----
Retained earnings
-7.23%-58.44M
1.76%-56.45M
---54.5M
-812.06%-57.46M
----
---6.3M
----
----
Gains losses not affecting retained earnings
33.55%347.25K
-2.73%351.2K
--260.02K
118.35%361.06K
----
--165.36K
----
----
Other equity interest
2,428.10%1.08M
--1.07M
--42.53K
----
----
----
-64.58%1.7M
--4.8M
Total stockholders'equity
1,045.50%11.87M
161.26%6.72M
-28.41%-1.26M
-5,374.09%-10.97M
---977.39K
-111.79%-200.45K
-64.58%1.7M
--4.8M
Total equity
1,045.50%11.87M
161.26%6.72M
-28.41%-1.26M
-5,374.09%-10.97M
---977.39K
-111.79%-200.45K
-64.58%1.7M
--4.8M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(Q2)Sep 30, 2025(FY)Mar 31, 2025(Q2)Sep 30, 2024(FY)Mar 31, 2024(Q2)Sep 30, 2023(FY)Mar 31, 2023(FY)Mar 31, 2022(FY)Mar 31, 2021
Assets
Current assets
Cash, cash equivalents and short term investments 269.98%7.15M736.78%6.14M222.96%1.93M-45.05%733.19K--598.38K-23.79%1.33M-63.17%1.75M--4.75M
-Cash and cash equivalents 269.98%7.15M736.78%6.14M222.96%1.93M-45.05%733.19K--598.38K-23.79%1.33M-63.17%1.75M--4.75M
Receivables 39.26%174.19K229.00%137.35K569.37%125.08K-72.05%41.75K--18.69K277.71%149.37K-71.36%39.55K--138.07K
-Other receivables 39.26%174.19K229.00%137.35K569.37%125.08K-72.05%41.75K--18.69K277.71%149.37K-71.36%39.55K--138.07K
Prepaid assets 65.27%258.09K-21.83%251.8K911.68%156.16K318.07%322.13K--15.44K1,329.54%77.05K-1.24%5.39K--5.46K
Restricted cash 59.37%47.19K21.45%35.96K-11.00%29.61K0.19%29.61K--33.27K-18.41%29.56K814.56%36.23K--3.96K
Total current assets 240.09%7.63M482.27%6.56M236.96%2.24M-29.15%1.13M--665.78K-13.20%1.59M-62.63%1.83M--4.9M
Non current assets
Net PPE -14.18%8.69K102.22%11.1K--10.13K--5.49K------0--------
-Gross PPE 30.25%15.83K172.46%15.6K--12.16K--5.73K------0--------
-Accumulated depreciation -252.00%-7.14K-1,778.33%-4.51K---2.03K---240------0--------
Investments and advances --5.17M--745K------0----------------
Total non current assets 51,062.26%5.18M13,679.77%756.1K--10.13K--5.49K--0--0--0--0
Total assets 468.46%12.81M546.23%7.32M238.48%2.25M-28.81%1.13M--665.78K-13.20%1.59M-62.63%1.83M--4.9M
Liabilities
Current liabilities
Payables -70.72%235.87K-53.42%261.94K-11.48%805.61K-65.46%562.35K--910.08K4,313.67%1.63M174.29%36.89K--13.45K
-accounts payable -70.72%235.87K-53.42%261.94K-11.48%805.61K-65.46%562.35K--910.08K4,313.67%1.63M174.29%36.89K--13.45K
Current accrued expenses 773.08%104.94K-59.92%50.48K--12.02K-22.52%125.95K----71.34%162.56K8.27%94.87K--87.63K
Current provisions 642.55%303.9K22.35%81.85K--40.93K--66.9K----------------
Current debt and capital lease obligation --------241.14%2.5M--10.45M--733.09K------------
-Current debt --------241.14%2.5M--10.45M--733.09K------------
Other current liabilities 100.00%298.37K-77.81%200.1K--149.18K--901.61K----------------
Current liabilities -73.12%943.07K-95.09%594.37K113.53%3.51M575.98%12.1M--1.64M1,259.04%1.79M30.36%131.76K--101.08K
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0
Total liabilities -73.12%943.07K-95.09%594.37K113.53%3.51M575.98%12.1M--1.64M1,259.04%1.79M30.36%131.76K--101.08K
Shareholders'equity
Share capital 30.12%68.88M33.88%61.75M--52.94M677.29%46.13M------5.93M--------
-common stock 30.12%68.88M33.88%61.75M--52.94M677.29%46.13M------5.93M--------
Retained earnings -7.23%-58.44M1.76%-56.45M---54.5M-812.06%-57.46M-------6.3M--------
Gains losses not affecting retained earnings 33.55%347.25K-2.73%351.2K--260.02K118.35%361.06K------165.36K--------
Other equity interest 2,428.10%1.08M--1.07M--42.53K-------------64.58%1.7M--4.8M
Total stockholders'equity 1,045.50%11.87M161.26%6.72M-28.41%-1.26M-5,374.09%-10.97M---977.39K-111.79%-200.45K-64.58%1.7M--4.8M
Total equity 1,045.50%11.87M161.26%6.72M-28.41%-1.26M-5,374.09%-10.97M---977.39K-111.79%-200.45K-64.58%1.7M--4.8M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion--Unqualified Opinion with Explanatory Notes--------
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -